Last reviewed · How we verify
A Prospective Phase II Trial of Vinorelbine Plus Oxaliplatin in Pretreated Metastatic Triple-negative Breast Cancer (NVBOX)
The purpose of this study is to evaluate the efficacy and safety of vinorelbine plus oxaliplatin in pretreated metastatic triple-negative breast cancer.
Details
| Lead sponsor | Fudan University |
|---|---|
| Phase | Phase 2 |
| Status | UNKNOWN |
| Enrolment | 35 |
| Start date | 2011-12 |
| Completion | 2013-07 |
Conditions
- Breast Cancer
Interventions
- vinorelbine plus oxaliplatin
Primary outcomes
- progression free survival — 6 weeks
Countries
China